Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
May 07, 2019
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Entity Registrant Name Checkpoint Therapeutics, Inc.  
Entity Central Index Key 0001651407  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Small Business true  
Common Stock [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   29,164,565
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   7,000,000